Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Sahm

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Clinical Microbiology|November 1, 1995
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on EnterococciJ M Swenson, M J Ferraro, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
A new high-level gentamicin resistance gene, aph(2'')-Id, in Enterococcus sppS F Tsai, M J Zervos, D B Clewell, et al.
Diagnostic Microbiology and Infectious Disease|July 25, 2000
Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre studyM E Jones, A M Staples, I Critchley, et al.
Journal of Clinical Microbiology|August 2, 2000
Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2J H Jorgensen, A L Barry, M M Traczewski, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seasonM E Jones, D F Sahm, N Martin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001R Blosser-Middleton, D F Sahm, C Thornsberry, et al.
Chemotherapy|September 19, 2001
Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococciC Thornsberry, J A Karlowsky, L J Kelly, et al.
Journal of Clinical Microbiology|March 30, 2002
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplaninL R Baden, I A Critchley, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial PathogensD J Biedenbach, S K Bouchillon, M Hackel, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Microbiology|November 1, 1995
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on EnterococciJ M Swenson, M J Ferraro, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
A new high-level gentamicin resistance gene, aph(2'')-Id, in Enterococcus sppS F Tsai, M J Zervos, D B Clewell, et al.
Diagnostic Microbiology and Infectious Disease|July 25, 2000
Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre studyM E Jones, A M Staples, I Critchley, et al.
Journal of Clinical Microbiology|August 2, 2000
Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2J H Jorgensen, A L Barry, M M Traczewski, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seasonM E Jones, D F Sahm, N Martin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2003
Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001R Blosser-Middleton, D F Sahm, C Thornsberry, et al.
Chemotherapy|September 19, 2001
Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococciC Thornsberry, J A Karlowsky, L J Kelly, et al.
Journal of Clinical Microbiology|March 30, 2002
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplaninL R Baden, I A Critchley, D F Sahm, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial PathogensD J Biedenbach, S K Bouchillon, M Hackel, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Pageof 9